Jiangsu Hengrui Pharmaceuticals Co., Ltd. is a global pharmaceutical company engaged in the development and commercialization of innovative and high-quality drugs, focusing on the research and development of new drugs in the fields of anti-tumor, surgical drugs, autoimmune diseases, metabolic diseases and cardiovascular diseases. Innovation is the core development strategy. Hengrui has 12 innovative products and 1 cooperative innovative product marketed, more than 60 innovative candidates in the R&D stage, and more than 260 trials under clinical development around the world. Hengrui ranked 24th among the top 1,000 global pharma companies announced by the Torreya in 2021. We have been on the Pharma Exec's annual listing of the top global pharmaceutical companies for the fourth consecutive year, rising from 47th in 2019 to 32nd in 2022.
此公司進入各市場的次序 — 由最舊至最新
註冊以查看完整訊號動態
Hengrui Pharma Co.,Ltd 的國際擴張與競爭對手的比較
Hengrui Pharma Co.,Ltd你長條顯示所比較各公司之間的相對規模。
欄位5| 公司 | 市場 | 新市場 | 動能 | 活動 | 擴張評分 |
|---|---|---|---|---|---|
 Hengrui Pharma Co.,Ltd你 | 0 | 0 | 0% | 0 | 32 |
Director, Transaction Attorney
查看招聘Shanghai, China · 上年
Pharmaceutical Ch
查看招聘Jiangsu, China · 上年
临床管培生--肿瘤医学
查看招聘Shanghai, China · 上年
無進行中的廣告活動
註冊以追蹤此公司，並在發生變化時第一時間獲得提醒。
暫無近期新聞
註冊以追蹤此公司，並在發生變化時第一時間獲得提醒。
解鎖已驗證電郵與直撥電話
免費 · 無需信用卡
關於 Hengrui Pharma Co.,Ltd 業務、市場及增長訊號的快速解答。
